GSK GSK PLC-SPON ADRUS
Everything important about one stock — one page ·
$49.24
-0.83%
Quote 25 Sept 2026, 23:00 KSA
Day move−0.83%
$49.24
Easy Score48
Neutral
Indicators1/18
1 bullish · 10 neutral · 7 bearish
Trend — 6 months−8.5%
Down
BullishNeutralBearish
Trend — daily 6 months
Down -8.5% — sellers are in control
Trend — weekly 3 years
Up +30.9% — rising but under its average — momentum cooling
48
Easy Score — Neutral
Analysts 32
Buy 14Hold 15Sell 3
Key indicators — and what each means now 1 bullish / 7 bearish of 18
Bullish 1Neutral 10Bearish 7
| RSI (14) 43 | healthy — not overbought, not oversold | |
| vs 200-day MA -6% | below its long-term average = long-term pressure | |
| MACD neutral | momentum undecided | |
| Volume 1.1× | normal activity — no unusual crowd behavior | |
| September 3y win rate 67% | September closed green 2 of the last 3 years |
The read
Strong profitability at a fair price (P/E 16). Daily trend down, weekly trend up. Whole picture, not advice.
Analysis through completed session of 25 Sept, 3:00 am KSA · Full analysis →